Livforsakringsbolaget Skandia Omsesidigt Buys 1,500 Shares of Astera Labs, Inc. $ALAB

Livforsakringsbolaget Skandia Omsesidigt lifted its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 166.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,400 shares of the company’s stock after acquiring an additional 1,500 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Astera Labs were worth $263,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs in the 4th quarter worth $18,708,000. Nordea Investment Management AB purchased a new stake in Astera Labs during the fourth quarter valued at $2,028,000. Swedbank AB increased its position in Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after acquiring an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in Astera Labs in the fourth quarter valued at about $499,000. Finally, Revere Asset Management Inc purchased a new position in Astera Labs in the fourth quarter worth about $589,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of recent research reports. Morgan Stanley boosted their price target on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Roth Capital reiterated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. UBS Group raised their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a report on Monday, June 29th. Jefferies Financial Group restated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $275.75.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. The trade was a 9.62% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,037,724 shares of company stock valued at $507,157,341. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $350.62 on Thursday. The stock has a 50-day simple moving average of $344.76 and a two-hundred day simple moving average of $218.93. The firm has a market capitalization of $60.10 billion, a PE ratio of 236.91, a P/E/G ratio of 4.07 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $88.73 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue was up 93.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.